News
Ferrante di Ruffano L, Dinnes J, Chuchu N, Bayliss SE, Takwoingi Y, Davenport C, Matin RN, O'Sullivan C, Roskell D, Deeks JJ, Williams HC, Cochrane Skin Cancer Diagnostic Test Accuracy Group.
A frozen section with nodular basal cell carcinoma. The blue overlay represents the attention map predictions, and the yellow outlines denote the ground truth as determined by a pathologist. Inset: ...
ORLANDO, Fla. — Beyond appropriate use criteria for Mohs surgery outlined by a multidisciplinary ad hoc task force in 2012, choice of treatment for superficial skin cancers like basal cell ...
TOPLINE: In a randomized trial, recurrence was higher after superficial curettage (SC) plus imiquimod cream than surgical excision (SE) in patients with nodular basal cell carcinoma (nBCC ...
Ressler, J. M., et al. (2025) Efficacy and tolerability of neoadjuvant therapy with Talimogene laherparepvec in cutaneous basal cell carcinoma: a phase II trial (NeoBCC trial). Nature Cancer. doi ...
A phase 3 study of Ameluz and RhodoLED photodynamic therapy for superficial basal cell carcinoma has reached a key milestone as the final patient has completed the 1-year follow-up visit ...
Biofrontera Inc. announced that the last patient in its Phase 3 study, ALA-BCC-CT013, of Ameluz and RhodoLED PDT for treating superficial basal cell carcinoma (sBCC) completed their one-year ...
In the U.S. alone, an estimated 3.6 million cases are diagnosed each year, a subset of which is superficial basal cell carcinoma.
About Basal Cell Carcinoma BCC is the most common form of skin cancer and the most frequently occurring form of all cancers. In the U.S. alone, an estimated 3.6 million cases are diagnosed each year, ...
Background: Basal cell carcinoma (BCC) is a type of skin cancer. It typically develops in areas exposed to the sun, such as the face, neck, and hands. BCC usually appears as a raised, pearly bump with ...
Preliminary results from a phase 3 trial demonstrate that photodynamic therapy with Ameluz (aminolevulinic acid HCl) led to complete clearance of a target lesion in patients with superficial basal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results